Problems of biomedical technologies legal regulation in Russia and abroad

The work provides an overview of contemporary normative acts of the Russian Federation devoted to specific aspects of biomedicine: reproductive technologies, genetic engineering activity and genomic testing, treatment of embryos and fetal tissue. We analyze the draft federal law «On biomedical cell products», passed by the State Duma on 21 April 2015 in the first reading. The drawbacks of the project, presented the main points of view in terms of its legal regulation, formulated by a professional society of lawyers and experts in the field of cell technology. An overseas and international experience. In particular, the general provisions of the legislation of France, Germany, the Convention on Human Rights and Biomedicine, developed by the Council of Europe and adopted in Oviedo in 1997, the European Directive (2004/23 / EC) for the establishment of standards of quality and safety of organ donation, collection, testing, handling, storage and distribution of human tissues and cells We formulate a general conclusion on the need for the base of the Federal Law «On Biomedicine», which could only be resolved key issues that are at the peak of the scientific discussion of the professional community, affecting basic human rights All technological issues need to be resolved at the level of subordinate legislation

legal regulation, biomedical technology, cellular product, foreign law, international standards